Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |